Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 7
1985 14
1986 40
1987 64
1988 79
1989 123
1990 267
1991 327
1992 366
1993 346
1994 375
1995 410
1996 451
1997 488
1998 596
1999 691
2000 873
2001 899
2002 940
2003 961
2004 982
2005 1036
2006 1184
2007 1230
2008 1377
2009 1631
2010 1806
2011 2024
2012 2208
2013 2391
2014 2360
2015 2327
2016 2410
2017 2254
2018 2028
2019 2111
2020 2036
2021 1842
2022 1447
2023 1254
2024 479

Text availability

Article attribute

Article type

Publication date

Search Results

40,289 results

Results by year

Filters applied: . Clear all
Page 1
The Frequency of Ras Mutations in Cancer.
Prior IA, Hood FE, Hartley JL. Prior IA, et al. Cancer Res. 2020 Jul 15;80(14):2969-2974. doi: 10.1158/0008-5472.CAN-19-3682. Epub 2020 Mar 24. Cancer Res. 2020. PMID: 32209560 Free PMC article. Review.
Drugging RAS: Moving Beyond KRASG12C.
[No authors listed] [No authors listed] Cancer Discov. 2023 Dec 12;13(12):OF7. doi: 10.1158/2159-8290.CD-ND2023-0010. Cancer Discov. 2023. PMID: 37871268
Next batter up! Targeting cancers with KRAS-G12D mutations.
Zeissig MN, Ashwood LM, Kondrashova O, Sutherland KD. Zeissig MN, et al. Trends Cancer. 2023 Nov;9(11):955-967. doi: 10.1016/j.trecan.2023.07.010. Epub 2023 Aug 15. Trends Cancer. 2023. PMID: 37591766 Free article. Review.
Annual review of KRAS inhibitors in 2022.
Wang H, Chi L, Yu F, Dai H, Gao C, Si X, Wang Z, Liu L, Zheng J, Shan L, Liu H, Zhang Q. Wang H, et al. Eur J Med Chem. 2023 Mar 5;249:115124. doi: 10.1016/j.ejmech.2023.115124. Epub 2023 Jan 16. Eur J Med Chem. 2023. PMID: 36680986 Review.
GTP-binding proteins in plants.
Bischoff F, Molendijk A, Rajendrakumar CS, Palme K. Bischoff F, et al. Cell Mol Life Sci. 1999 Feb;55(2):233-56. doi: 10.1007/s000180050287. Cell Mol Life Sci. 1999. PMID: 10188584 Review.
Targeting Oncogenic RAS Protein.
Longo DL, Rosen N. Longo DL, et al. N Engl J Med. 2022 Jul 14;387(2):184-186. doi: 10.1056/NEJMe2206831. N Engl J Med. 2022. PMID: 35830646 No abstract available.
An allosteric pan-TEAD inhibitor blocks oncogenic YAP/TAZ signaling and overcomes KRAS G12C inhibitor resistance.
Hagenbeek TJ, Zbieg JR, Hafner M, Mroue R, Lacap JA, Sodir NM, Noland CL, Afghani S, Kishore A, Bhat KP, Yao X, Schmidt S, Clausen S, Steffek M, Lee W, Beroza P, Martin S, Lin E, Fong R, Di Lello P, Kubala MH, Yang MN, Lau JT, Chan E, Arrazate A, An L, Levy E, Lorenzo MN, Lee HJ, Pham TH, Modrusan Z, Zang R, Chen YC, Kabza M, Ahmed M, Li J, Chang MT, Maddalo D, Evangelista M, Ye X, Crawford JJ, Dey A. Hagenbeek TJ, et al. Nat Cancer. 2023 Jun;4(6):812-828. doi: 10.1038/s43018-023-00577-0. Epub 2023 Jun 5. Nat Cancer. 2023. PMID: 37277530 Free PMC article.
40,289 results
You have reached the last available page of results. Please see the User Guide for more information.